Internship

Software Developer Intern

Confirmed live in the last 24 hours

Resmed

Resmed

5,001-10,000 employees

Develops cloud-connected medical devices for chronic diseases

Compensation Overview

$22.50 - $41.50/hr

No H1B Sponsorship

Halifax Regional Municipality, NS, Canada

This is a hybrid role, requiring some in-office presence in Halifax, Nova Scotia.

Category
Full-Stack Engineering
Software Engineering
Required Skills
Python
Java
Requirements
  • Ability to work full-time for 12 weeks during Summer 2025; program dates are May 19, 2025 – August 8, 2025 OR June 16, 2025 – September 5, 2025
  • Computer Science academic studies that will lead to a Bachelors in Computer Science.
  • Experience with Java or Python is an asset.
Responsibilities
  • Work directly with a mentor in your field of study while finding solutions to real world problems
  • Experience our products up close by working with one of our Digital Engineering teams
  • Interact directly with our company leaders
  • Work on an internal support tool MVP to help with internal monitoring of our IoT devices.
Desired Qualifications
  • Excellent critical thinking and problem-solving skills.
  • Strong experiences as demonstrated through projects, research or computer science internships.
  • Great interpersonal relations, team cooperation and communication skills.
  • Exceptional organizational and collaboration skills as demonstrated through leadership positions on teams and/or in student or civic organizations.
  • Exceptional communication skills and interest and enthusiasm related to medical technology industry and a career with ResMed.

ResMed develops medical devices and software platforms designed to treat and manage conditions like sleep apnea and chronic obstructive pulmonary disease (COPD). Their products are cloud-connected, allowing for better monitoring and management of patients' health. ResMed's offerings include both medical devices and software subscriptions, which provide ongoing support and services. What sets ResMed apart from its competitors is its focus on reducing hospital visits and healthcare costs while improving the quality of life for patients. The company's goal is to enhance patient care and support healthcare professionals and caregivers across more than 120 countries.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

San Diego, California

Founded

1989

Simplify Jobs

Simplify's Take

What believers are saying

  • Growing sleep apnea market boosts demand for ResMed's products.
  • Telehealth adoption aligns with ResMed's cloud-connected device strategy.
  • AI integration in healthcare offers innovation opportunities for ResMed.

What critics are saying

  • Increased competition may impact ResMed's market share.
  • Rising raw material costs could squeeze profit margins.
  • Data privacy concerns may lead to regulatory scrutiny.

What makes Resmed unique

  • ResMed offers cloud-connected devices for sleep apnea and chronic disease management.
  • The company operates in over 120 countries, providing a global healthcare solution.
  • ResMed integrates AI in diagnostics, enhancing personalized treatment options.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Paid Vacation

Paid Holidays

Parental Leave

401(k) Retirement Plan

Employee Assistance Program (EAP)

Company News

MarketBeat
Feb 28th, 2025
Proficio Capital Partners LLC Invests $50.36 Million in ResMed Inc. (NYSE:RMD)

Proficio Capital Partners LLC invests $50.36 million in ResMed Inc. (NYSE:RMD).

Healthier Tomorrow
Feb 26th, 2025
ResMed Survey: Despite Sleep Problems, Few Willing to Take Proactive Steps

ResMed today unveiled the findings of its fifth annual Global Sleep Survey.

MarketBeat
Feb 22nd, 2025
Alberta Investment Management Corp Invests $2.38 Million in ResMed Inc. (NYSE:RMD)

Alberta Investment Management Corp invests $2.38 million in ResMed Inc. (NYSE:RMD).

India Med Today
Jan 10th, 2025
ResMed launches AirSense 11 for sleep apnea patients

ResMed launches airsense 11 for sleep apnea patients.

ResMed
Jan 6th, 2025
ResMed Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference

ResMed Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference